Schumer/Waxman Call For Industry Groups To Condemn Generic Drug Payoffs
In letters to PhRMA and GPhA, legislators point to FTC report detailing industry settlements as a sign of growing anti-competitive activity.
In letters to PhRMA and GPhA, legislators point to FTC report detailing industry settlements as a sign of growing anti-competitive activity.